Valliance Asset Management Ltd Takes $162.85 Million Position in Astera Labs, Inc. $ALAB

Valliance Asset Management Ltd acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 337,150 shares of the company’s stock, valued at approximately $162,850,000. Astera Labs comprises about 18.8% of Valliance Asset Management Ltd’s portfolio, making the stock its 3rd biggest holding. Valliance Asset Management Ltd owned 0.19% of Astera Labs as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Nykredit A S bought a new position in shares of Astera Labs in the second quarter worth $23,699,000. EMC Capital Management bought a new stake in Astera Labs during the 2nd quarter valued at $97,000. B. Metzler seel. Sohn & Co. AG increased its holdings in Astera Labs by 18.1% during the 2nd quarter. B. Metzler seel. Sohn & Co. AG now owns 3,424 shares of the company’s stock valued at $1,654,000 after purchasing an additional 524 shares during the period. Secure Asset Management LLC bought a new stake in shares of Astera Labs during the 2nd quarter valued at about $226,000. Finally, Vanguard Capital Wealth Advisors purchased a new position in shares of Astera Labs during the 2nd quarter worth approximately $290,000. Institutional investors own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the completion of the transaction, the director directly owned 3,970 shares in the company, valued at approximately $1,237,965.10. This represents a 69.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. JPMorgan Chase & Co. raised their price target on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Citigroup reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. UBS Group restated a “neutral” rating and set a $425.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Finally, Bank of America increased their target price on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $333.00.

Astera Labs Price Performance

Shares of ALAB stock traded down $7.89 during trading on Friday, reaching $282.63. The company’s stock had a trading volume of 1,756,522 shares, compared to its average volume of 5,446,093. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The company has a market capitalization of $49.03 billion, a price-to-earnings ratio of 139.92 and a beta of 3.84. The stock’s 50-day moving average price is $354.34 and its 200 day moving average price is $244.64.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue was up 104.5% on a year-over-year basis. During the same period last year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.